查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
電子處方解決方案市場 - 全球市場規模、佔有率、趨勢分析、機遇和預測報告，2019-2029
市場調查報告書
商品編碼
1310406

電子處方解決方案市場 - 全球市場規模、佔有率、趨勢分析、機遇和預測報告，2019-2029

E-Prescribing Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Delivery Mode ; By Usage Method ; By Substances ; By Specialties ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

到 2029 年，全球電子處方解決方案市場將成長五倍以上，達到 138 億美元

由於越來越注重減少欺詐和濫用受控藥物、疾病患病率上升以及減少醫療差錯，全球電子處方解決方案市場正在蓬勃發展。

領先的戰略諮詢和市場研究公司 BlueWeave Consulting 最近估計，2022 年全球電子處方解決方案市場規模為 27.4 億美元。 BlueWeave預測，2023年至2029年的預測期內，全球電子處方解決方案市場規模將以26.04%的年複合成長率大幅成長，到2029年將達到137.9億美元。全球電子處方解決方案市場的主要成長促進因素是醫療保健 IT 解決方案的日益普及、減少用藥錯誤和提高患者安全的需求以及促進電子處方系統採用的政府政策。專注於數位化和醫療保健自動化。電子處方解決方案通過為醫療保健專業人員提供準確和最新的藥物資訊（包括推薦劑量、過敏和潛在的藥物相互作用），對於減少用藥錯誤和提高患者安全至關重要。隨著患者安全成為醫療保健領域的首要任務，對電子處方解決方案的需求持續成長。此外，糖尿病、心血管疾病和呼吸系統疾病等慢性病的全球患病率不斷上升，進一步需要使用電子處方解決方案。這些解決方案有效管理慢性病患者的藥物治療，減少錯誤並確保及時開藥。因此，慢性病負擔的增加正在推動全球電子處方解決方案市場的擴張。然而，高部署成本、安全性和工作流程問題預計將在預測期內抑制整個市場的成長。

該報告的詳細分析提供了有關全球電子處方解決方案市場的成長潛力、未來趨勢和統計數據的資訊。我們還關注推動市場總規模預測的因素。該報告承諾提供全球電子處方解決方案市場的最新技術發展以及行業見解，幫助決策者做出明智的戰略決策。它還分析了市場的成長促進因素、挑戰和競爭力。

目錄

第1章 研究框架

第2章 執行摘要

第3章 全球電子處方解決方案市場洞察

  • 行業價值鏈分析
  • DROC分析
    • 成長促進因素
      • 殘疾患病率上升
      • 人們對減少醫療差錯越來越感興趣
      • 專注於減少欺詐和管製藥物濫用
    • 抑制因素
      • 引進成本高
      • 安全和工作流程問題
    • 機會
      • 由於 COVID-19，整合 Telepath 解決方案的採用率有所提高
      • 政府加大對醫療基礎設施的投資
    • 任務
      • 消費者缺乏科技意識
  • 技術進步/最新發展
  • 監管框架
  • 波特五力分析

第4章 全球電子處方解決方案市場概述

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 副產品
      • 解決方案
      • 綜合解決方案
      • 獨立解決方案
      • 服務
      • 支持
      • 執行
      • 訓練
      • 通訊網路
    • 按交貨方式
      • 基於網路/雲
      • 本地
    • 使用方法
      • 手持式
      • 基於電腦的設備
    • 按物質
      • 管制物質
      • 不受控制的物質
    • 按專業
      • 腫瘤學
      • 運動藥物
      • 神經病學
      • 心臟病學
      • 其他
    • 按最終用戶
      • 醫院
      • 主治醫師
      • 藥店
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第5章 北美電子處方解決方案市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 副產品
    • 按交貨方式
    • 使用方法
    • 按物質
    • 按專業
    • 按最終用戶
    • 按國家/地區
      • 美國
      • 加拿大

第6章 歐洲電子處方解決方案市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 副產品
    • 按交貨方式
    • 使用方法
    • 按物質
    • 按專業
    • 按最終用戶
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第7章 亞太電子處方解決方案市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 副產品
    • 按交貨方式
    • 使用方法
    • 按物質
    • 按專業
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和紐西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他地區

第8章 拉丁美洲電子處方解決方案市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 副產品
    • 按交貨方式
    • 使用方法
    • 按物質
    • 按專業
    • 按最終用戶
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 拉丁美洲其他地區

第9章 中東和非洲電子處方解決方案市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 副產品
    • 按交貨方式
    • 使用方法
    • 按物質
    • 按專業
    • 按最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • MEA 的其餘部分

第10章 競爭格局

  • 主要公司及其產品列表
  • 2022年全球電子處方解決方案企業市場佔有率分析
  • 通過運行參數進行競爭基準測試
  • 主要戰略發展（合併、收購、合作夥伴關係等）

第11章COVID-19 對全球電子處方解決方案市場的影響

第12章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭、聯繫地址、戰略展望、SWOT分析）

  • Medical information technology, Inc.
  • Eclinicalworks
  • Athenahealth
  • Epic Systems Corporation
  • Change healthcare
  • Surescripts
  • Practice Fusion
  • Drfirst
  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • NextGen Healthcare, Inc.
  • eMDs, Inc.
  • Greenway Health, LLC
  • Stratice Healthcare
  • Computer Programs and Systems Inc.
  • Other Prominent Players

第13章關鍵戰略建議

第14章調查方法

  • 定性研究
    • 初級和次級研究
  • 定量研究
  • 市場細分和數據三角測量
    • 二次調查
    • 初步調查
  • 主要調查受訪者的地區分佈
  • 假設和限制
簡介目錄
Product Code: BWC23562

Global E-Prescribing Solutions Market Size Zooming More Than 5X to Touch USD 13.8 Billion by 2029.

Global e-prescribing solutions market is flourishing because of an increasing focus on the reduction of fraud and abuse of controlled substances and rising prevalence of disorders, increasing focus on reducing medical errors.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global e-prescribing solutions market size at USD 2.74 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global e-prescribing solutions market size to grow at a significant CAGR of 26.04% reaching a value of USD 13.79 billion by 2029. Major growth drivers for the global e-prescribing solutions market include an increasing adoption of healthcare IT solutions, the need to minimize medication errors and improve patient safety, government initiatives promoting the adoption of e-prescribing systems, and the growing emphasis on digitization and healthcare automation. E-prescribing solutions have a pivotal role in reducing medication errors and enhancing patient safety by equipping healthcare professionals with accurate and up-to-date information on medications, including dosage recommendations, allergies, and potential drug interactions. As healthcare prioritizes patient safety, the demand for e-prescribing solutions continues to grow. Also, the rising prevalence of chronic diseases like diabetes, cardiovascular diseases, and respiratory conditions on a global scale further necessitates the use of e-prescribing solutions. These solutions effectively manage medication for patients with chronic conditions, ensuring timely prescriptions while reducing errors. Consequently, the increasing burden of chronic diseases acts as a driving force behind the expanding global e-prescribing solutions market. However, high cost of deployment and concern regarding security and workflow are anticipated to restrain the overall market growth during the forecast period.

Global E-Prescribing Solutions Market - Overview:

The global e-prescribing solutions market refers to the market encompassing electronic prescription systems used in the healthcare industry. E-prescribing, or electronic prescribing, involves the computer-based generation, transmission, and management of medical prescriptions, replacing traditional paper-based methods. The e-prescribing solutions market includes software platforms and solutions that enable healthcare professionals to electronically create, transmit, and process prescriptions, as well as access patient medication history, drug interaction alerts, and formulary information. The global e-prescribing solutions market is driven by the need to enhance patient safety, minimize medication errors, improve healthcare efficiency, and comply with government regulations promoting digital healthcare initiatives.

Impact of COVID-19 on Global E-Prescribing Solutions Market:

COVID-19 pandemic had a positive impact on the global e-prescribing solutions market. With the focus on reducing physical contact and ensuring patient safety, there has been a heightened demand for contactless healthcare solutions. E-prescribing systems have played a crucial role in enabling remote prescribing, minimizing the need for in-person visits to healthcare facilities. The pandemic has accelerated the adoption of e-prescribing solutions as healthcare providers strive to streamline workflows, reduce transmission risks, and ensure continuity of care. Moreover, the transition towards telemedicine and virtual consultations has underscored the significance of e-prescribing, consequently fueling market expansion both during and after the COVID-19 pandemic.

Global E-Prescribing Solutions Market - By End User:

On basis of the End User, the global e-prescribing solutions market is segmented into Hospital, Office-based Physicians, and Pharmacy segments. The office-based physicians segment holds the highest share in the global e-prescribing solutions market by end user. These include the widespread adoption of e-prescribing systems in outpatient settings, the convenience and efficiency it offers to office-based physicians in managing prescriptions, and the ability to seamlessly integrate e-prescribing with electronic health records for streamlined patient care. Meanwhile, the hospital segment dominates the market in second place. Hospitals are large healthcare facilities that handle a significant volume of patient visits and medication prescriptions. Implementing e-prescribing systems in hospitals helps improve efficiency, reduce medication errors, and enhance patient safety. Additionally, hospitals often have more complex medication management needs, including controlled substances and specialized treatments, which can be effectively managed through e-prescribing solutions. The integration of e-prescribing systems with other hospital systems, such as electronic health records and pharmacy systems, further enhances workflow and coordination, contributing to the segment's significant market share.

Competitive Landscape:

Major players operating in the Global E-Prescribing Solutions Market include: Medical information technology, Inc., Eclinicalworks, Athenahealth, Epic Systems Corporation, Change healthcare, Surescripts, Practice Fusion, Drfirst, Allscripts Healthcare Solutions, Inc., Cerner Corporation, NextGen Healthcare, Inc., eMDs, Inc., Greenway Health, LLC, Stratice Healthcare, and Computer Programs and Systems Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global E-Prescribing Solutions Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global E-Prescribing Solutions Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global E-Prescribing Solutions Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising prevalence of disorders
      • 3.2.1.2. Increasing focus on reducing medical errors
      • 3.2.1.3. Rise in focus on the reduction of fraud and abuse of controlled substances
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of deployment
      • 3.2.2.2. Concern regarding security and workflow
    • 3.2.3. Opportunities
      • 3.2.3.1. Increasing adoption of integrated telepath solution due to COVID-19
      • 3.2.3.2. Increase in government investments on healthcare infrastructure
    • 3.2.4. Challenges
      • 3.2.4.1. Lack of technological awareness among consumers
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global E-Prescribing Solutions Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Solutions
      • 4.2.1.1.1. Integrated Solutions
      • 4.2.1.1.2. Standalone Solutions
      • 4.2.1.2. Services
      • 4.2.1.2.1. Support
      • 4.2.1.2.2. Implementation
      • 4.2.1.2.3. Training
      • 4.2.1.2.4. Network
    • 4.2.2. By Delivery Mode
      • 4.2.2.1. Web/Cloud-Based
      • 4.2.2.2. On-premises
    • 4.2.3. By Usage Method
      • 4.2.3.1. Handheld
      • 4.2.3.2. Computer-based Devices
    • 4.2.4. By Substances
      • 4.2.4.1. Controlled Substances
      • 4.2.4.2. Non-controlled Substances
    • 4.2.5. By Specialties
      • 4.2.5.1. Oncology
      • 4.2.5.2. Sports Medicine
      • 4.2.5.3. Neurology
      • 4.2.5.4. Cardiology
      • 4.2.5.5. Others
    • 4.2.6. By End User
      • 4.2.6.1. Hospital
      • 4.2.6.2. Office-based Physicians
      • 4.2.6.3. Pharmacy
    • 4.2.7. By Region
      • 4.2.7.1. North America
      • 4.2.7.2. Europe
      • 4.2.7.3. Asia Pacific (APAC)
      • 4.2.7.4. Latin America (LATAM)
      • 4.2.7.5. Middle East and Africa (MEA)

5. North America E-Prescribing Solutions Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Delivery Mode
    • 5.2.3. By Usage Method
    • 5.2.4. By Substances
    • 5.2.5. By Specialties
    • 5.2.6. By End User
    • 5.2.7. By Country
      • 5.2.7.1. United States
      • 5.2.7.1.1. By Product
      • 5.2.7.1.2. By Delivery Mode
      • 5.2.7.1.3. By Usage Method
      • 5.2.7.1.4. By Substances
      • 5.2.7.1.5. By Specialties
      • 5.2.7.1.6. By End User
      • 5.2.7.2. Canada
      • 5.2.7.2.1. By Product
      • 5.2.7.2.2. By Delivery Mode
      • 5.2.7.2.3. By Usage Method
      • 5.2.7.2.4. By Substances
      • 5.2.7.2.5. By Specialties
      • 5.2.7.2.6. By End User

6. Europe E-Prescribing Solutions Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Delivery Mode
    • 6.2.3. By Usage Method
    • 6.2.4. By Substances
    • 6.2.5. By Specialties
    • 6.2.6. By End User
    • 6.2.7. By Country
      • 6.2.7.1. Germany
      • 6.2.7.1.1. By Product
      • 6.2.7.1.2. By Delivery Mode
      • 6.2.7.1.3. By Usage Method
      • 6.2.7.1.4. By Substances
      • 6.2.7.1.5. By Specialties
      • 6.2.7.1.6. By End User
      • 6.2.7.2. United Kingdom
      • 6.2.7.2.1. By Product
      • 6.2.7.2.2. By Delivery Mode
      • 6.2.7.2.3. By Usage Method
      • 6.2.7.2.4. By Substances
      • 6.2.7.2.5. By Specialties
      • 6.2.7.2.6. By End User
      • 6.2.7.3. Italy
      • 6.2.7.3.1. By Product
      • 6.2.7.3.2. By Delivery Mode
      • 6.2.7.3.3. By Usage Method
      • 6.2.7.3.4. By Substances
      • 6.2.7.3.5. By Specialties
      • 6.2.7.3.6. By End User
      • 6.2.7.4. France
      • 6.2.7.4.1. By Product
      • 6.2.7.4.2. By Delivery Mode
      • 6.2.7.4.3. By Usage Method
      • 6.2.7.4.4. By Substances
      • 6.2.7.4.5. By Specialties
      • 6.2.7.4.6. By End User
      • 6.2.7.5. Spain
      • 6.2.7.5.1. By Product
      • 6.2.7.5.2. By Delivery Mode
      • 6.2.7.5.3. By Usage Method
      • 6.2.7.5.4. By Substances
      • 6.2.7.5.5. By Specialties
      • 6.2.7.5.6. By End User
      • 6.2.7.6. Belgium
      • 6.2.7.6.1. By Product
      • 6.2.7.6.2. By Delivery Mode
      • 6.2.7.6.3. By Usage Method
      • 6.2.7.6.4. By Substances
      • 6.2.7.6.5. By Specialties
      • 6.2.7.6.6. By End User
      • 6.2.7.7. Russia
      • 6.2.7.7.1. By Product
      • 6.2.7.7.2. By Delivery Mode
      • 6.2.7.7.3. By Usage Method
      • 6.2.7.7.4. By Substances
      • 6.2.7.7.5. By Specialties
      • 6.2.7.7.6. By End User
      • 6.2.7.8. The Netherlands
      • 6.2.7.8.1. By Product
      • 6.2.7.8.2. By Delivery Mode
      • 6.2.7.8.3. By Usage Method
      • 6.2.7.8.4. By Substances
      • 6.2.7.8.5. By Specialties
      • 6.2.7.8.6. By End User
      • 6.2.7.9. Rest of Europe
      • 6.2.7.9.1. By Product
      • 6.2.7.9.2. By Delivery Mode
      • 6.2.7.9.3. By Usage Method
      • 6.2.7.9.4. By Substances
      • 6.2.7.9.5. By Specialties
      • 6.2.7.9.6. By End User

7. Asia-Pacific E-Prescribing Solutions Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Delivery Mode
    • 7.2.3. By Usage Method
    • 7.2.4. By Substances
    • 7.2.5. By Specialties
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Product
      • 7.2.6.1.2. By Delivery Mode
      • 7.2.6.1.3. By Usage Method
      • 7.2.6.1.4. By Substances
      • 7.2.6.1.5. By Specialties
      • 7.2.6.1.6. By End User
      • 7.2.6.2. India
      • 7.2.6.2.1. By Product
      • 7.2.6.2.2. By Delivery Mode
      • 7.2.6.2.3. By Usage Method
      • 7.2.6.2.4. By Substances
      • 7.2.6.2.5. By Specialties
      • 7.2.6.2.6. By End User
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Product
      • 7.2.6.3.2. By Delivery Mode
      • 7.2.6.3.3. By Usage Method
      • 7.2.6.3.4. By Substances
      • 7.2.6.3.5. By Specialties
      • 7.2.6.3.6. By End User
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Product
      • 7.2.6.4.2. By Delivery Mode
      • 7.2.6.4.3. By Usage Method
      • 7.2.6.4.4. By Substances
      • 7.2.6.4.5. By Specialties
      • 7.2.6.4.6. By End User
      • 7.2.6.5. Australia & New Zealand
      • 7.2.6.5.1. By Product
      • 7.2.6.5.2. By Delivery Mode
      • 7.2.6.5.3. By Usage Method
      • 7.2.6.5.4. By Substances
      • 7.2.6.5.5. By Specialties
      • 7.2.6.5.6. By End User
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Product
      • 7.2.6.6.2. By Delivery Mode
      • 7.2.6.6.3. By Usage Method
      • 7.2.6.6.4. By Substances
      • 7.2.6.6.5. By Specialties
      • 7.2.6.6.6. By End User
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Product
      • 7.2.6.7.2. By Delivery Mode
      • 7.2.6.7.3. By Usage Method
      • 7.2.6.7.4. By Substances
      • 7.2.6.7.5. By Specialties
      • 7.2.6.7.6. By End User
      • 7.2.6.8. Singapore
      • 7.2.6.8.1. By Product
      • 7.2.6.8.2. By Delivery Mode
      • 7.2.6.8.3. By Usage Method
      • 7.2.6.8.4. By Substances
      • 7.2.6.8.5. By Specialties
      • 7.2.6.8.6. By End User
      • 7.2.6.9. Vietnam
      • 7.2.6.9.1. By Product
      • 7.2.6.9.2. By Delivery Mode
      • 7.2.6.9.3. By Usage Method
      • 7.2.6.9.4. By Substances
      • 7.2.6.9.5. By Specialties
      • 7.2.6.9.6. By End User
      • 7.2.6.10. Rest of APAC
      • 7.2.6.10.1. By Product
      • 7.2.6.10.2. By Delivery Mode
      • 7.2.6.10.3. By Usage Method
      • 7.2.6.10.4. By Substances
      • 7.2.6.10.5. By Specialties
      • 7.2.6.10.6. By End User

8. Latin America E-Prescribing Solutions Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Delivery Mode
    • 8.2.3. By Usage Method
    • 8.2.4. By Substances
    • 8.2.5. By Specialties
    • 8.2.6. By End User
    • 8.2.7. By Country
      • 8.2.7.1. Brazil
      • 8.2.7.1.1. By Product
      • 8.2.7.1.2. By Delivery Mode
      • 8.2.7.1.3. By Usage Method
      • 8.2.7.1.4. By Substances
      • 8.2.7.1.5. By Specialties
      • 8.2.7.1.6. By End User
      • 8.2.7.2. Mexico
      • 8.2.7.2.1. By Product
      • 8.2.7.2.2. By Delivery Mode
      • 8.2.7.2.3. By Usage Method
      • 8.2.7.2.4. By Substances
      • 8.2.7.2.5. By Specialties
      • 8.2.7.2.6. By End User
      • 8.2.7.3. Argentina
      • 8.2.7.3.1. By Product
      • 8.2.7.3.2. By Delivery Mode
      • 8.2.7.3.3. By Usage Method
      • 8.2.7.3.4. By Substances
      • 8.2.7.3.5. By Specialties
      • 8.2.7.3.6. By End User
      • 8.2.7.4. Peru
      • 8.2.7.4.1. By Product
      • 8.2.7.4.2. By Delivery Mode
      • 8.2.7.4.3. By Usage Method
      • 8.2.7.4.4. By Substances
      • 8.2.7.4.5. By Specialties
      • 8.2.7.4.6. By End User
      • 8.2.7.5. Rest of LATAM
      • 8.2.7.5.1. By Product
      • 8.2.7.5.2. By Delivery Mode
      • 8.2.7.5.3. By Usage Method
      • 8.2.7.5.4. By Substances
      • 8.2.7.5.5. By Specialties
      • 8.2.7.5.6. By End User

9. Middle East & Africa E-Prescribing Solutions Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Delivery Mode
    • 9.2.3. By Usage Method
    • 9.2.4. By Substances
    • 9.2.5. By Specialties
    • 9.2.6. By End User
    • 9.2.7. By Country
      • 9.2.7.1. Saudi Arabia
      • 9.2.7.1.1. By Product
      • 9.2.7.1.2. By Delivery Mode
      • 9.2.7.1.3. By Usage Method
      • 9.2.7.1.4. By Substances
      • 9.2.7.1.5. By Specialties
      • 9.2.7.1.6. By End User
      • 9.2.7.2. UAE
      • 9.2.7.2.1. By Product
      • 9.2.7.2.2. By Delivery Mode
      • 9.2.7.2.3. By Usage Method
      • 9.2.7.2.4. By Substances
      • 9.2.7.2.5. By Specialties
      • 9.2.7.2.6. By End User
      • 9.2.7.3. Qatar
      • 9.2.7.3.1. By Product
      • 9.2.7.3.2. By Delivery Mode
      • 9.2.7.3.3. By Usage Method
      • 9.2.7.3.4. By Substances
      • 9.2.7.3.5. By Specialties
      • 9.2.7.3.6. By End User
      • 9.2.7.4. Kuwait
      • 9.2.7.4.1. By Product
      • 9.2.7.4.2. By Delivery Mode
      • 9.2.7.4.3. By Usage Method
      • 9.2.7.4.4. By Substances
      • 9.2.7.4.5. By Specialties
      • 9.2.7.4.6. By End User
      • 9.2.7.5. South Africa
      • 9.2.7.5.1. By Product
      • 9.2.7.5.2. By Delivery Mode
      • 9.2.7.5.3. By Usage Method
      • 9.2.7.5.4. By Substances
      • 9.2.7.5.5. By Specialties
      • 9.2.7.5.6. By End User
      • 9.2.7.6. Nigeria
      • 9.2.7.6.1. By Product
      • 9.2.7.6.2. By Delivery Mode
      • 9.2.7.6.3. By Usage Method
      • 9.2.7.6.4. By Substances
      • 9.2.7.6.5. By Specialties
      • 9.2.7.6.6. By End User
      • 9.2.7.7. Algeria
      • 9.2.7.7.1. By Product
      • 9.2.7.7.2. By Delivery Mode
      • 9.2.7.7.3. By Usage Method
      • 9.2.7.7.4. By Substances
      • 9.2.7.7.5. By Specialties
      • 9.2.7.7.6. By End User
      • 9.2.7.8. Rest of MEA
      • 9.2.7.8.1. By Product
      • 9.2.7.8.2. By Delivery Mode
      • 9.2.7.8.3. By Usage Method
      • 9.2.7.8.4. By Substances
      • 9.2.7.8.5. By Specialties
      • 9.2.7.8.6. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global E-Prescribing Solutions Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global E-Prescribing Solutions Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Medical information technology, Inc.
  • 12.2. Eclinicalworks
  • 12.3. Athenahealth
  • 12.4. Epic Systems Corporation
  • 12.5. Change healthcare
  • 12.6. Surescripts
  • 12.7. Practice Fusion
  • 12.8. Drfirst
  • 12.9. Allscripts Healthcare Solutions, Inc.
  • 12.10. Cerner Corporation
  • 12.11. NextGen Healthcare, Inc.
  • 12.12. eMDs, Inc.
  • 12.13. Greenway Health, LLC
  • 12.14. Stratice Healthcare
  • 12.15. Computer Programs and Systems Inc.
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations